THREE-COMPONENT ANTI-HYPERYTENSION THERAPY – PROSPECTS OF APPLICATION

The high prevalence of arterial hypertension (AH) – up to 40% of the whole population (and more than 50% among elderly patients) – makes it one of the most important problems of the modern medicine. In the report of the World Health Organization AH is called the first reason of mortality worldwide [3]. Reduction of increased arterial hypertension and achievement of its target value are of paramount importance for improvement of the forecast by cardiovascular complications in AH patients